Investor Ideas #Potcasts
598, #Cannabis News and #Stocks on the Move; (TSX: $VLNS.TO) (OTCQX: $VLNCF),
(CSE: $BHSC.C), (CSE: $HARV.C) (OTCQX: $HRVSF), (CSE: $XTRX.C)
Delta, Kelowna, BC, August 19, 2021 (Invstorideas.com Newswire) www.Investoride, as.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/081921-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/08191VLNS-BHSC-HARV-XTRX.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
BioHarvest
Sciences Inc.'s (CSE: BHSC) today unveiled a new, groundbreaking
"Amalgamated Trichomes Coral Structure" (ATCS) that will
revolutionize the production of Cannabis.
BioHarvest has successfully grown multiple trichomes in coral-shaped
clusters where they are attached together in a natural structure. This structure
protects the trichomes from the shear forces and guarantees much-needed
mechanical stability during the growth process.
The trichomes (the natural
cannabinoids micro-factories of the Cannabis plant – picture 3) grow on the
surface of the Cannabis flower or leaf and have a shape of a tiny mushroom with
glandular heads.
They are individually and
mechanically attached to the surface through a fragile stalk. BioHarvest is the
first company in the world to successfully and naturally grow trichomes
together, forming a coral-shaped structure (pictures 1 and 2) that protects
them from the shear forces applied by the fluid motion inside the bioreactors.
This structure guarantees the much-needed mechanical stability during the
growth process within the bioreactor. We call this uniquely shaped structure
"Amalgamated Trichomes Coral Structure" (ATCS), and it allows the
Company to quickly scale up Cannabis production in advance of wide scale
commercialization in H1 2022.
Dr. Yochi Hagay, CTO of BioHarvest,
said: "ATCS is instrumental in the ability to grow trichomes cells in
bioreactors at scale. Over the last decade, BioHarvest's world-class R&D
team demonstrated unparalleled expertise in plant cell biology. This
achievement is particularly notable given the complexity of Cannabis, and I
have no doubt in this team's ability to apply it on any plant in the
future."
Ilan Sobel, CEO of BioHarvest, said:
"ATCS brings us one step closer to the completion of the Cannabis
development program. The patented BioFarming technology, along with such
in-house expertise, is creating tremendous biotech market opportunities for
BioHarvest. I look forward to showing the world in H1/2022 the Company's
Cannabis-based products and to unveiling new conquered frontiers by our BioFarming
technology."
Eitan Popper, Chairman of
BioHarvest's Board of Advisors, and Co-Founder and former President of
MedReleaf, stated: "One of the main questions I raised when I first met
BioHarvest's management, was whether the Company's technology would allow for
Cannabis trichomes to stably grow in liquid media. Even intuitively, this is
far from trivial, as Cannabis trichome cells grown in liquid media lack the
static mechanical support they have when growing on top of or attached to the
solid Cannabis flower or leaf tissue. The challenge is two-fold, not only
liquid media vs. solid plant tissue but also dynamic flow conditions vs. static
conditions. Put simply, how do you stably proliferate and guarantee the
physical integrity of fragile plant organs grown in a liquid that is
circulating or flowing within a bioreactor. BioHarvest has solved this with
proprietary IP that is specific to Cannabis. It is fascinating from a
scientific point of view and very encouraging from a business potential
perspective for Cannabis and beyond."
The Valens Company
Inc. (TSX: VLNS) (OTCQX: VLNCF), a leading manufacturer of
cannabis products, today announced that its subsidiary Green
Roads has entered into a third-party distribution agreement with Tele Marche
Co., Ltd. for the sale and distribution by Tele Marche Co of Green Roads'
award-winning CBD products in Japan.
Tele
Marche Co, in consultation with Green Roads, developed an online store in Japan
by leveraging insights and best practices from Green Roads' strong e-commerce
and marketing platform in the US, which averages approximately 9,000 orders per
month and boasts over 30,000 five-star product reviews. The online store in
Japan also includes various educational resources to help consumers learn more
about cannabidiol (CBD), the importance of lab testing for safety and quality,
and how to choose a product that best suits their preferences.
"We
are very excited to join forces with Tele Marche Co so that they can bring
Japanese consumers our award-winning CBD products that many consumers in the
United States and beyond have come to trust for their quality, consistency, and
value," said Dale Baker, President, US of The Valens Company. "We are
confident that this new online store, along with its robust consumer education,
will meet the growing needs of Japanese CBD consumers and will achieve success
similar to that of our US e-commerce platform."
A
full range of Green Roads' CBD products are now available to Japanese consumers
through the online store, including tinctures, pet products, gummies,
chocolate, bath bombs, and capsules. The
online store in Japan will be owned and operated by Tele Marche Co under
license from Green Roads.
Tyler
Robson, Chief Executive Officer, Co-Founder and Chair of The Valens Company
added: "We are incredibly proud to add Japan to the growing list of
countries in which Green Roads' products are available. With a population of
approximately 127 million1, we view Japan as a significant growth opportunity
with untapped potential for leading North American CBD brands like Green Roads.
With Green Roads and Valens' products now collectively available in over 12
countries, we are rapidly increasing our distribution exposure and
strategically positioning our platform to service many emerging markets poised
for significant growth in new global regions."
Harvest Health
& Recreation Inc. (CSE: HARV) (OTCQX: HRVSF), a vertically integrated
cannabis company and multi-state operator in the U.S., today announced that it has obtained the final
order from the Supreme Court of British Columbia approving the previously
announced arrangement agreement, pursuant to which Trulieve Cannabis Corp. has
agreed to acquire all of the issued and outstanding shares of Harvest.
"We
are pleased to have reached another milestone as we work toward closing the
Trulieve transaction," said Chief Executive Officer Steve White. "We
have and will continue to work collaboratively with the entire Trulieve team
until we obtain all of required regulatory approvals needed to close."
This
follows the company announcing the opening of a new medical
dispensary in Philadelphia, Pennsylvania.
Harvest
of South Philadelphia is located at 501 South Broad St, Philadelphia and is
open Monday through Saturday from 9:00 am to 8:00 pm and Sunday from 10:00 am
to 6:00 pm.
More
information for patients about the new medical dispensary location can be found
at: https://www.harvesthoc.com/locations/pennsylvania/philadelphia/harvest-of-philadelphia-broad/
Additional
Harvest-affiliated dispensaries in Pennsylvania are located in Camp Hill,
Cranberry Township, Harrisburg, Johnstown, King of Prussia, Reading (two
locations), Scranton, Whitehall, and York.
"We
are pleased to open our eleventh Harvest-affiliated dispensary in Pennsylvania,
one of the fastest growing medical markets in the U.S." said Chief
Executive Officer Steve White. "We look forward to serving patients and
providing quality products at this new location in one of our core
markets."
Phyto
Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE: XTRX) announced that it has submitted a licence
amendment to Health Canada that, if approved, will enable Phyto to sell dried
cannabis flower to provincially authorized distributors and retailers and
registered medical patients.
The licence amendment would allow
Phyto's wholly owned Health Canada licenced subsidiary, Adastra Labs Inc., to leverage its agricultural product
fulfillment capabilities to package, produce and sell dried flower based
products across Canada, which would open the pathway to higher profit margins
by eliminating the necessity to sell to other licence holders.
Michael Forbes, CEO and a director
of Phyto, states, "The ability to sell dried cannabis products directly to
provincial distributors and retailers represents a major milestone in the
development of Phyto's growth-oriented business plan. Direct sales will
increase margins and provide critical access to retail space as flower and
pre-rolls represent the largest cannabis market segments in Canada while
bringing more eyes to our brands."
Dried Cannabis products are in high demand from provincial
distributors and medical clients. Sales continue to dominate the legal Canadian
recreational market, accounting for roughly three quarters of all sales and totaling
over $2 billion in 2020.1"We intend to leverage Phyto's brand awareness
and sales momentum in the concentrates space to commercialize dried cannabis
products under the brand to drive topline revenue with these high gross margin
products," said Donald Dinsmore, COO, Corporate Secretary and a director
of Phyto.
Investor
ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and that this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment.
Learn
more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
To hear
more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
The Investorideas.com podcasts are also
available on iTunes ( Apple Podcasts) ,
Audible , Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio , Google Podcasts and most audio platforms
available.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third
party stock research , guest posts and original
articles and podcasts in leading stock sectors. Learn about investing in stocks and get investor ideas in cannabis, crypto, AI and
IoT, mining, sports biotech, water, renewable energy, gaming and more. Investor
Idea’s original branded content includes podcasts and columns : Crypto
Corner , Play by Play sports and stock news , Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast
, Cleantech and Climate Change , Exploring Mining , Betting on Gaming Stocks Podcast and the AI Eye
Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where
permissible by law. Our site does not possess, distribute, or sell cannabis
products.
Follow
us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for iPhone and Android
Join our
Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665
0411
Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory
No comments:
Post a Comment